Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective (Q74450936)
scientific article published on 01 November 1998
Language:
(P31) (Q13442814)
(P50) (Q63436698)
(P304) 1894-1901
(P433) 12
(P478) 34
(P577) Sunday, November 1, 1998
(P921) (Q423762)
(Q412415)
(P1433) (Q332260)
(P1476) "Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective" (language: en)
(P2093) T Fischer
T D Szucs
(P2860) (Q50609607)
(Q41032444)
(Q40816415)
(Q40397088)
(Q40673230)
(Q71574814)
(Q41374429)
(Q71102143)
(Q73117362)
(Q71828011)
(Q52713010)
(Q34299363)
(Q68780660)
(Q34550152)
(Q44906277)
(Q44298631)
(Q45094348)
(Q44942727)
(Q41235538)
(Q52655617)
(Q72880127)
other details
description scientific article published on 01 November 1998

External Links